Evaluation of Microsphere-based xMAP Test for gyrA Mutation Identification in Mycobacterium Tuberculosis  

作　　者：OU Xi Chao ZHAO Bing SONG Ze Xuan PEI Shao Jun WANG Sheng Fen HE Wen Cong LIU Chun Fa LIU Dong Xin XING Rui Da XIA Hui ZHAO Yan Lin 

机构地区：[1]National Center for Tuberculosis Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China [2]School of Public Health,Peking University,Beijing 100191,China

出　　处：《Biomedical and Environmental Sciences》2023年第4期384-387,共4页生物医学与环境科学（英文版）

基　　金：funded by the National Key R&D Program [2022YFC2305200];China CDC-Tuberculosis Control and Prevention Project [228711]。

摘　　要：Drug-resistant(DR) tuberculosis(TB) is a growing threat to public health[1]. Fluoroquinolone(FQ) antibiotics have long been used as anti-tuberculosis drugs, and their widespread application has led to the development of resistance in clinical isolates of Mycobacterium tuberculosis complex(MTBC).

关 键 词：TUBERCULOSIS drugs MYCOBACTERIUM 

分 类 号：R378.911[医药卫生—病原生物学]